Literature DB >> 18047547

An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1.

S B Jeimy, E F Krakow, N Fuller, S Tasneem, C P M Hayward.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18047547     DOI: 10.1111/j.1538-7836.2007.02860.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  6 in total

Review 1.  Acquired factor V inhibitors: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

2.  Location of the multimerin 1 binding site in coagulation factor V: an update.

Authors:  Samira B Jeimy; Mary Ann Quinn-Allen; Nola Fuller; William H Kane; Catherine P M Hayward
Journal:  Thromb Res       Date:  2008-05-02       Impact factor: 3.944

Review 3.  Multimerin-1 and cancer: a review.

Authors:  Mareike G Posner
Journal:  Biosci Rep       Date:  2022-02-25       Impact factor: 3.840

4.  Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer.

Authors:  Bofang Wang; Dan Zou; Na Wang; Haotian Wang; Tao Zhang; Lei Gao; Chenhui Ma; Peng Zheng; Baohong Gu; Xuemei Li; Yunpeng Wang; Puyi He; Yanling Ma; Xueyan Wang; Hao Chen
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

5.  Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.

Authors:  Mengyu Sun; Jieping Qiu; Huazheng Zhai; Yaoqun Wang; Panpan Ma; Mengyin Li; Bo Chen
Journal:  Med Sci Monit       Date:  2020-08-02

6.  Thrombin generation abnormalities in Quebec platelet disorder.

Authors:  Justin G Brunet; Tanmya Sharma; Subia Tasneem; Minggao Liang; Michael D Wilson; Georges E Rivard; Catherine P M Hayward
Journal:  Int J Lab Hematol       Date:  2020-08-06       Impact factor: 2.877

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.